Literature DB >> 17400311

Comparisons of short- and intermediate-term effects of pitavastatin versus atorvastatin on lipid profiles, fibrinolytic parameter, and endothelial function.

Koichi Sakabe, Nobuo Fukuda, Yamato Fukuda, Katsunori Wakayama, Teru Nada, Satofumi Morishita, Hisanori Shinohara, Yoshiyuki Tamura.   

Abstract

We compared short- and intermediate-term effects on lipid profiles, fibrinolytic parameter, and endothelial function between pitavastatin and atorvastatin. Short-term improvement of endothelial function was superior with pitavastatin compared to atorvastatin therapy. Pitavastatin could be a potentially better therapeutic choice for lipid-lowering and early alterations in endothelial function. Our study provides an important basis on which further trials involving larger numbers of patients may be studied prospectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400311     DOI: 10.1016/j.ijcard.2007.01.040

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  13 in total

1.  Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia.

Authors:  Bonpei Takase; Hidemi Hattori; Yoshihiro Tanaka; Masayoshi Nagata; Masayuki Ishihara
Journal:  Heart Asia       Date:  2013-09-13

Review 2.  Pitavastatin: a review of its use in the management of hypercholesterolaemia or mixed dyslipidaemia.

Authors:  Sean T Duggan
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

Review 3.  Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals.

Authors:  Yasushi Saito
Journal:  Vasc Health Risk Manag       Date:  2009-11-16

4.  Atorvastatin increases myocardial indices of oxidative stress in a porcine model of hypercholesterolemia and chronic ischemia.

Authors:  Neel R Sodha; Munir Boodhwani; Basel Ramlawi; Richard T Clements; Shigetoshi Mieno; Jun Feng; Shu-Hua Xu; Cesario Bianchi; Frank W Sellke
Journal:  J Card Surg       Date:  2008 Jul-Aug       Impact factor: 1.620

5.  The administration of pitavastatin augments creatinine clearance associated with reduction in oxidative stress parameters: acute and early effects.

Authors:  Hirokazu Kakuda; Keizo Kanasaki; Daisuke Koya; Noboru Takekoshi
Journal:  Clin Exp Nephrol       Date:  2012-09-05       Impact factor: 2.801

Review 6.  Pleiotropic effects of pitavastatin.

Authors:  Jean Davignon
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

Review 7.  Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia.

Authors:  Jun Sasaki
Journal:  Vasc Health Risk Manag       Date:  2010-11-02

Review 8.  Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus.

Authors:  Yasuyuki Kawai; Ryoko Sato-Ishida; Atsushi Motoyama; Kouji Kajinami
Journal:  Drug Des Devel Ther       Date:  2011-05-11       Impact factor: 4.162

9.  Pitavastatin for lowering lipids.

Authors:  Stephen P Adams; Nima Alaeiilkhchi; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2020-06-19

10.  Very rapid effect of pitavastatin on microvascular function in comparison to rosuvastatin: reactive hyperemia peripheral arterial tonometric study.

Authors:  Yasushi Kono; Shota Fukuda; Kenei Shimada; Koki Nakanishi; Kenichiro Otsuka; Tomoichiro Kubo; Satoshi Jissho; Haruyuki Taguchi; Junichi Yoshikawa; Minoru Yoshiyama
Journal:  Drug Des Devel Ther       Date:  2013-05-03       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.